Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
The American Journal of Physiology
|
June 1, 1988
Physiological measurement of luminal stirring in perfused rat jejunum
B W Anderson, A S Levine, D G Levitt, et al.
Annals of Surgical Oncology
|
December 30, 1998
Ovarian cancer-associated lymphocyte recognition of folate binding protein peptides
G E Peoples, B W Anderson, B Fisk, et al.
Urology
|
July 22, 1998
Wilms' tumor with renal cell carcinoma overgrowth in a 3-year-old child
B W Anderson, D B Halverstadt, D J Culkin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 6, 2000
Peptide priming of cytolytic activity to HER-2 epitope 369-377 in healthy individuals
B W Anderson, G E Peoples, J L Murray, et al.
Oncology Reports
|
April 18, 2000
Identification of activated tumor antigen-reactive CD8+ cells in healthy individuals
T V Lee, B W Anderson, G E Peoples, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2000
Vaccine implications of folate binding protein, a novel cytotoxic T lymphocyte-recognized antigen system in epithelial cancers
G E Peoples, B W Anderson, T V Lee, et al.
Cancer Immunology, Immunotherapy : CII
|
November 25, 2000
Induction of determinant spreading and of Th1 responses by in vitro stimulation with HER-2 peptides
B W Anderson, A P Kudelka, T Honda, et al.
Molecular Immunology
|
July 8, 1999
Ovarian and breast cytotoxic T lymphocytes can recognize peptides from the amino enhancer of split protein of the Notch complex
B Babcock, B W Anderson, I Papayannopoulos, et al.
Cancer Research
|
January 1, 1997
Identification of naturally processed human ovarian peptides recognized by tumor-associated CD8+ cytotoxic T lymphocytes
B Fisk, B W Anderson, K R Gravitt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 26, 1998
Proliferative and cytokine responses to class II HER-2/neu-associated peptides in breast cancer patients
T M Tuttle, B W Anderson, W E Thompson, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
The American Journal of Physiology
|
June 1, 1988
Physiological measurement of luminal stirring in perfused rat jejunum
B W Anderson, A S Levine, D G Levitt, et al.
Annals of Surgical Oncology
|
December 30, 1998
Ovarian cancer-associated lymphocyte recognition of folate binding protein peptides
G E Peoples, B W Anderson, B Fisk, et al.
Urology
|
July 22, 1998
Wilms' tumor with renal cell carcinoma overgrowth in a 3-year-old child
B W Anderson, D B Halverstadt, D J Culkin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 6, 2000
Peptide priming of cytolytic activity to HER-2 epitope 369-377 in healthy individuals
B W Anderson, G E Peoples, J L Murray, et al.
Oncology Reports
|
April 18, 2000
Identification of activated tumor antigen-reactive CD8+ cells in healthy individuals
T V Lee, B W Anderson, G E Peoples, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2000
Vaccine implications of folate binding protein, a novel cytotoxic T lymphocyte-recognized antigen system in epithelial cancers
G E Peoples, B W Anderson, T V Lee, et al.
Cancer Immunology, Immunotherapy : CII
|
November 25, 2000
Induction of determinant spreading and of Th1 responses by in vitro stimulation with HER-2 peptides
B W Anderson, A P Kudelka, T Honda, et al.
Molecular Immunology
|
July 8, 1999
Ovarian and breast cytotoxic T lymphocytes can recognize peptides from the amino enhancer of split protein of the Notch complex
B Babcock, B W Anderson, I Papayannopoulos, et al.
Cancer Research
|
January 1, 1997
Identification of naturally processed human ovarian peptides recognized by tumor-associated CD8+ cytotoxic T lymphocytes
B Fisk, B W Anderson, K R Gravitt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 26, 1998
Proliferative and cytokine responses to class II HER-2/neu-associated peptides in breast cancer patients
T M Tuttle, B W Anderson, W E Thompson, et al.
Page
of 3